ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2039

Uveitis Surveillance Through Lean-Six Sigma for Quality Assurance in Juvenile Idiopathic Arthritis

Anjali Patwardhan1, Kelly Kelleher2, Jeffery Hoffman3, Karla B. Jones4, Stacy P. Ardoin5 and Charles H. Spencer6, 1Pediatric Rheumatology, Nationwide Childrens Hospital, Columbus, OH, 2Pediatric Research and innovation, Nationwide Childrens Hospital, Columbus, OH, 3Emergency Medicine, Nationwide Childrens Hospital, Columbus, OH, 4Rheumatology ED260- 2S, Nationwide Children's Hospital, Columbus, OH, 5Pediatric & Adult Rheumatology, Ohio State University College of Medicine, Columbus, OH, 6Rheumatology, Nationwide Childrens Hospital, Columbus, OH

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Juvenile Arthritis, quality of care and utilization review

  • Tweet
  • Email
  • Print
Session Information

Title: Quality Measures and Innovations in Practice Management and Care Delivery

Session Type: Abstract Submissions (ACR)

Background/Purpose:  Chronic asymptomatic iridocyclitis occurs in 10-20% of all patients with JIA leading to insidious but progressive morbidity and possible blindness. Patients with JIA-associated uveitis need to be seen by an ophthalmologist regularly. Lean thinking is based upon the following principles. 1) Identifying the customer value (value adding steps) and  alleviating the redundant parts of the process hence minimize waste 2) developing an effective flow production 3) eliminate backflows 4)using “pull” techniques 5) striving to perfection

Methods: Various tools of lean methodology were used throughout the development of a new process of uveitis surveillance for JIA patients visiting rheumatology clinics at Nationwide Children’s Hospital. Problems were identified after paper chart review of 400 JIA patients. The key performance indicators used were 1) number of patients given eye examination request sheet 2) number of eye examination results received back from eye doctors & 3) number of eye examination results documented and available during the clinic visit. The hospital has switched to electronic medical records (EPIC) since 2006. It was found on baseline data that uveitis surveillance was inadequate and ineffective in paper charts. We identified the need to develop an electronic health record – based new surveillance process which can be more effective in improving communication between eye doctors, rheumatologists and patients/parents. We performed value stream mapping by stake holders to sketch the initial process and identify bottlenecks. Delphi survey was then used to reach consensus decisions, though out the project time. We charted current state, future state & ideal state and performed gap analysis. We then developed a pareto- matrix. The project methodology was based on the Deming’s PDSA cycles. We developed a standard work based on our initial PDSA cycles. We evaluated the new process through KPIs

Results: The uveitis surveillance process improved inter-team communication and quality of care. Inbuilt alerts in the process for presence of eye disease and missed eye appointments prompted rheumatologist to take appropriate timely action

Conclusion: Implementation of lean tools and thinking can make provide smarter, quicker, easier, better and safer uveitis patient care delivery to the JIA patients by use of an effective uveitis surveillance process. We also emphasize the importance of seeing lean thinking as a part of the larger management shift towards planning for changes in mindsets and work places. This new surveillance process can be horizontally deployed for diabetic eye surveillance and drug toxicity monitoring in rheumatic patients on immunosuppressant


Disclosure:

A. Patwardhan,
None;

K. Kelleher,
None;

J. Hoffman,
None;

K. B. Jones,
None;

S. P. Ardoin,
None;

C. H. Spencer,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/uveitis-surveillance-through-lean-six-sigma-for-quality-assurance-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology